Total Payments
$8,798
2024 Payments
$1,264
Companies
49
Transactions
459
Medicare Patients
10,284
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$8,460 (96.2%)
Education$338.02 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,460 | 430 | 96.2% |
| Education | $338.02 | 29 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $848.17 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $745.06 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $704.66 | 44 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $696.99 | 50 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $672.31 | 29 | $0 (2024) |
| Amgen Inc. | $587.89 | 36 | $0 (2024) |
| Boston Scientific Corporation | $559.43 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $548.30 | 42 | $0 (2024) |
| Edwards Lifesciences Corporation | $247.05 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $222.77 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,264 | 49 | PFIZER INC. ($244.45) |
| 2023 | $1,298 | 69 | E.R. Squibb & Sons, L.L.C. ($226.16) |
| 2022 | $785.09 | 46 | E.R. Squibb & Sons, L.L.C. ($204.10) |
| 2021 | $1,136 | 52 | BOSTON SCIENTIFIC CORPORATION ($223.39) |
| 2020 | $354.00 | 20 | Amgen Inc. ($77.47) |
| 2019 | $1,810 | 91 | Boehringer Ingelheim Pharmaceuticals, Inc. ($316.46) |
| 2018 | $988.06 | 63 | Edwards Lifesciences Corporation ($120.36) |
| 2017 | $1,163 | 69 | Janssen Pharmaceuticals, Inc ($138.24) |
All Payment Transactions
459 individual payment records from CMS Open Payments — Page 3 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/08/2023 | Teleflex LLC | TWIN-PASS (Device) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Interventional Access | ||||||
| 11/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.88 | General |
| Category: Cardiovascular | ||||||
| 11/07/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.51 | General |
| Category: Cardiovascular | ||||||
| 10/31/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiology | ||||||
| 10/24/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Genetic Disease | ||||||
| 10/19/2023 | CMP Pharma, Inc. | Carospir (Drug), Norliqva, Tadliq | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Cardiology | ||||||
| 10/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: DIABETES | ||||||
| 10/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Cardiovascular | ||||||
| 10/06/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 09/19/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 09/05/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/31/2023 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: WATCHMAN Pro_IC | ||||||
| 08/26/2023 | Teleflex LLC | GUIDELINER (Device) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Interventional Access | ||||||
| 08/22/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/19/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: WATCHMAN_IC | ||||||
| 08/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiology | ||||||
| 08/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,473 | 6,603 | $1.2M | $306,120 |
| 2022 | 23 | 2,787 | 15,864 | $1.4M | $317,047 |
| 2021 | 20 | 2,560 | 11,978 | $1.2M | $296,356 |
| 2020 | 20 | 2,464 | 13,213 | $1.3M | $301,628 |
Total Patients
10,284
Total Services
47,658
Medicare Billing
$1.2M
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 741 | 1,289 | $431,815 | $112,213 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 180 | 289 | $130,628 | $37,778 | 28.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 267 | 275 | $195,525 | $37,287 | 19.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 100 | 100 | $153,200 | $34,014 | 22.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 99 | 198 | $37,620 | $14,839 | 39.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 93 | 372 | $30,132 | $14,653 | 48.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $41,040 | $9,223 | 22.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 148 | 148 | $35,224 | $7,065 | 20.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 34 | 34 | $27,132 | $6,685 | 24.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 110 | 111 | $25,090 | $5,606 | 22.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $19,350 | $5,071 | 26.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 50 | $12,700 | $4,389 | 34.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 31 | $15,314 | $4,063 | 26.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 26 | 26 | $16,666 | $3,698 | 22.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 21 | $11,466 | $3,477 | 30.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 139 | 151 | $7,642 | $1,473 | 19.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 64 | 67 | $6,700 | $1,358 | 20.3% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 34 | 3,060 | $24,480 | $1,224 | 5.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 148 | 174 | $8,214 | $1,028 | 12.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 64 | 67 | $3,015 | $615.42 | 20.4% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 15 | 15 | $1,200 | $274.33 | 22.9% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 15 | 15 | $435.00 | $84.37 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 788 | 1,399 | $468,665 | $121,438 | 25.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 306 | 320 | $227,520 | $43,862 | 19.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 117 | 117 | $179,244 | $39,545 | 22.1% |
About Dr. Harminder Gandhok, M.D
Dr. Harminder Gandhok, M.D is a Cardiovascular Disease healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053585935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harminder Gandhok, M.D has received a total of $8,798 in payments from pharmaceutical and medical device companies, with $1,264 received in 2024. These payments were reported across 459 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($8,460).
As a Medicare-enrolled provider, Gandhok has provided services to 10,284 Medicare beneficiaries, totaling 47,658 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Salem, OR
- Active Since 04/22/2008
- Last Updated 03/25/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1053585935
Products in Payments
- ELIQUIS (Drug) $1,102
- XARELTO (Drug) $700.18
- ENTRESTO (Drug) $490.65
- BRILINTA (Drug) $402.35
- JARDIANCE (Drug) $394.94
- Repatha (Biological) $328.99
- PRADAXA (Drug) $277.37
- Corlanor (Drug) $258.90
- VERQUVO (Drug) $222.77
- FARXIGA (Drug) $220.54
- VYNDAQEL (Drug) $220.54
- WATCHMAN Access System (Device) $196.38
- CAMZYOS (Drug) $169.70
- LifeVest (Device) $163.83
- WATCHMAN (Device) $155.40
- Impella (Device) $151.82
- BYSTOLIC (Drug) $135.54
- PRALUENT (Drug) $130.05
- GENERAL VASCULAR ACCESS (Device) $125.00
- SAMSCA (Drug) $117.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Salem
Kevin Thompson, Do, DO
Cardiovascular Disease — Payments: $101,034
Cardiovascular Disease $101,034
Ashit Patel, M.d, M.D
Cardiovascular Disease — Payments: $54,451
Cardiovascular Disease $54,451
Dr. Sandeep Saha, M.d, M.D
Cardiovascular Disease — Payments: $43,942
Cardiovascular Disease $43,942
Dr. Andrew Maiolo, Md, MD
Cardiovascular Disease — Payments: $19,968
Cardiovascular Disease $19,968
Maziar Azadpour, M.d, M.D
Cardiovascular Disease — Payments: $17,622
Cardiovascular Disease $17,622
Barath Krishnamurthy, Md, MD
Cardiovascular Disease — Payments: $13,695
Cardiovascular Disease $13,695